Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Market Cap: 122m AUD

Wall Street
Price Targets

MEB Price Targets Summary
Medibio Ltd

There are no price targets for MEB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Medibio Ltd Competitors:
Price Targets
PHF
Pharmagest Interactive SA
18% Upside
CERT
Certara Inc
49% Upside
2158
Yidu Tech Inc
49% Upside
300451
B-SOFT Co Ltd
28% Upside
WAY
Waystar Holding Corp
52% Upside
NXU
Nexus AG
0% Upside
SDGR
Schrodinger Inc
57% Upside
2150
CareNet Inc
14% Downside

Revenue
Forecast

Revenue Estimate
Medibio Ltd

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

18%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEB's stock price target?
Not Available

MEB doesn't have any price targets made by Wall Street professionals.

What is Medibio Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

Back to Top